Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up.

ABSTRACT:

Purpose

Few studies have reported on healthcare utilization and costs for intracranial meningioma patients, while the tumor and its treatment profoundly affect patients' functioning and well-being. Here we evaluated healthcare utilization and costs, including their determinants.

Methods

A multicenter cross-sectional study of adult meningioma patients ≥ 5 years after intervention. Patients completed three validated patient-reported outcome measures (PROMs) assessing patients 'functioning and wellbeing (SF-36, EORTC QLQ-BN20, and HADS) and a study-specific questionnaire assessing healthcare utilization over the previous twelve months. Healthcare costs of the twelve months prior were calculated using reported healthcare utilization ≥ 5 years after intervention by the Dutch Manu

SUBMITTER: Huynh KA 

PROVIDER: S-EPMC9988802 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature